2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid

C91H134N20O24S3 — CID 163601143

IUPAC2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid
SMILESCC[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC(=O)[C@H](C)NC(=O)CN(C)C(=O)CCN)CSCCC(=O)N2CCOCCN3CCOCCN(CCOCC2)C(=O)CCSC[C@@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)CSCCC3=O
InChIInChI=1S/C91H134N20O24S3/c1-9-61-84(125)103-68-51-138-40-23-76(119)110-30-36-134-33-27-108(74(117)21-38-136-49-58(82(123)106-80(55(7)112)90(131)99-61)43-70(113)54(6)97-72(115)48-107(8)73(116)20-24-92)26-32-133-34-28-109(29-35-135-37-31-110)75(118)22-39-137-50-67(81(93)122)102-88(129)69-19-14-25-111(69)91(132)79(53(4)5)105-85(126)64(41-56-45-94-62-17-12-10-15-59(56)62)98-71(114)47-96-83(124)66(44-77(120)121)101-89(130)78(52(2)3)104-86(127)65(100-87(68)128)42-57-46-95-63-18-13-11-16-60(57)63/h10-13,15-18,45-46,52-55,58,61,64-69,78-80,94-95,112H,9,14,19-44,47-51,92H2,1-8H3,(H2,93,122)(H,96,124)(H,97,115)(H,98,114)(H,99,131)(H,100,128)(H,101,130)(H,102,129)(H,103,125)(H,104,127)(H,105,126)(H,106,123)(H,120,121)/t54-,55+,58-,61-,64-,65-,66-,67-,68+,69-,78-,79-,80-/m0/s1
InChIKeyBEBZGYIWXXQEHL-NVQYPXAASA-N
MW1988.39 g/mol
LogP-3.20
Rot. Bonds19

About 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid

2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid (PubChem CID 163601143) has the molecular formula C91H134N20O24S3 and a molecular weight of 1988.39 g/mol. Its IUPAC name is 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid.

Molecular Properties

Compound Name2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid
PubChem CID163601143
Molecular FormulaC91H134N20O24S3
Molecular Weight1988.39 g/mol
Exact Mass1986.90
IUPAC Name2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid
SMILESCC[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC(=O)[C@H](C)NC(=O)CN(C)C(=O)CCN)CSCCC(=O)N2CCOCCN3CCOCCN(CCOCC2)C(=O)CCSC[C@@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)CSCCC3=O
InChIInChI=1S/C91H134N20O24S3/c1-9-61-84(125)103-68-51-138-40-23-76(119)110-30-36-134-33-27-108(74(117)21-38-136-49-58(82(123)106-80(55(7)112)90(131)99-61)43-70(113)54(6)97-72(115)48-107(8)73(116)20-24-92)26-32-133-34-28-109(29-35-135-37-31-110)75(118)22-39-137-50-67(81(93)122)102-88(129)69-19-14-25-111(69)91(132)79(53(4)5)105-85(126)64(41-56-45-94-62-17-12-10-15-59(56)62)98-71(114)47-96-83(124)66(44-77(120)121)101-89(130)78(52(2)3)104-86(127)65(100-87(68)128)42-57-46-95-63-18-13-11-16-60(57)63/h10-13,15-18,45-46,52-55,58,61,64-69,78-80,94-95,112H,9,14,19-44,47-51,92H2,1-8H3,(H2,93,122)(H,96,124)(H,97,115)(H,98,114)(H,99,131)(H,100,128)(H,101,130)(H,102,129)(H,103,125)(H,104,127)(H,105,126)(H,106,123)(H,120,121)/t54-,55+,58-,61-,64-,65-,66-,67-,68+,69-,78-,79-,80-/m0/s1
InChIKeyBEBZGYIWXXQEHL-NVQYPXAASA-N
XLogP-3.20
TPSA624.63 Ų
H-Bond Donors17
H-Bond Acceptors27
Rotatable Bonds19
Heavy Atoms138
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001988.39
LogP ≤ 5-3.20
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1027

Analyze 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid?
The IUPAC name of 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid (CID 163601143) is 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid.
What is the SMILES notation for 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid?
The canonical SMILES for 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid is CC[C@@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](CC(=O)[C@H](C)NC(=O)CN(C)C(=O)CCN)CSCCC(=O)N2CCOCCN3CCOCCN(CCOCC2)C(=O)CCSC[C@@H](NC1=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)CSCCC3=O.
What is the InChIKey of 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid?
The InChIKey is BEBZGYIWXXQEHL-NVQYPXAASA-N. The full InChI is InChI=1S/C91H134N20O24S3/c1-9-61-84(125)103-68-51-138-40-23-76(119)110-30-36-134-33-27-108(74(117)21-38-136-49-58(82(123)106-80(55(7)112)90(131)99-61)43-70(113)54(6)97-72(115)48-107(8)73(116)20-24-92)26-32-133-34-28-109(29-35-135-37-31-110)75(118)22-39-137-50-67(81(93)122)102-88(129)69-19-14-25-111(69)91(132)79(53(4)5)105-85(126)64(41-56-45-94-62-17-12-10-15-59(56)62)98-71(114)47-96-83(124)66(44-77(120)121)101-89(130)78(52(2)3)104-86(127)65(100-87(68)128)42-57-46-95-63-18-13-11-16-60(57)63/h10-13,15-18,45-46,52-55,58,61,64-69,78-80,94-95,112H,9,14,19-44,47-51,92H2,1-8H3,(H2,93,122)(H,96,124)(H,97,115)(H,98,114)(H,99,131)(H,100,128)(H,101,130)(H,102,129)(H,103,125)(H,104,127)(H,105,126)(H,106,123)(H,120,121)/t54-,55+,58-,61-,64-,65-,66-,67-,68+,69-,78-,79-,80-/m0/s1.
What are the key properties of 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid?
2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid has a molecular weight of 1988.39 g/mol, XLogP of -3.20, 19 rotatable bonds, 17 hydrogen bond donors, and 27 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(13R,16S,22S,25S,31S,34S,37S,40S,43S,46S,49R)-49-[(3S)-3-[[2-[3-aminopropanoyl(methyl)amino]acetyl]amino]-2-oxobutyl]-13-carbamoyl-43-ethyl-46-[(1R)-1-hydroxyethyl]-25,37-bis(1H-indol-3-ylmethyl)-8,15,21,24,27,30,33,36,39,42,45,48,54,61-tetradecaoxo-22,34-di(propan-2-yl)-4,58,68-trioxa-11,51,64-trithia-1,7,14,20,23,26,29,32,35,38,41,44,47,55-tetradecazatetracyclo[38.20.5.57,55.016,20]heptacontan-31-yl]acetic acid is sourced from PubChem (CID 163601143), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).